关注
Lorenzo Gemignani
Lorenzo Gemignani
在 unige.it 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance–pH off therapy
E Savarino, R Tutuian, P Zentilin, P Dulbecco, D Pohl, E Marabotto, ...
Official journal of the American College of Gastroenterology| ACG 105 (5 …, 2010
2652010
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial
E Savarino, G Bodini, P Dulbecco, L Assandri, L Bruzzone, F Mazza, ...
Official journal of the American College of Gastroenterology| ACG 108 (11 …, 2013
2482013
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro‐oesophageal reflux disease
E Savarino, L Gemignani, D Pohl, P Zentilin, P Dulbecco, L Assandri, ...
Alimentary pharmacology & therapeutics 34 (4), 476-486, 2011
2342011
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn
E Savarino, P Zentilin, L Mastracci, P Dulbecco, E Marabotto, ...
Journal of gastroenterology 48, 473-482, 2013
2272013
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease
E Savarino, E Marabotto, P Zentilin, M Frazzoni, G Sammito, D Bonfanti, ...
Digestive and Liver Disease 43 (7), 542-547, 2011
1912011
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients
E Savarino, P Zentilin, R Tutuian, D Pohl, L Gemignani, A Malesci, ...
Journal of gastroenterology 47, 159-168, 2012
1492012
Characteristics of gastro‐esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers
E Savarino, P Zentilin, M Frazzoni, DL Cuoco, D Pohl, P Dulbecco, ...
Neurogastroenterology & Motility 22 (10), 1061-e280, 2010
1062010
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth
M Furnari, A Parodi, L Gemignani, EG Giannini, S Marenco, E Savarino, ...
Alimentary pharmacology & therapeutics 32 (8), 1000-1006, 2010
932010
Overweight is a risk factor for both erosive and non-erosive reflux disease
E Savarino, P Zentilin, E Marabotto, D Bonfanti, S Inferrera, L Assandri, ...
Digestive and Liver Disease 43 (12), 940-945, 2011
882011
Reassessment of the role of methane production between irritable bowel syndrome and functional constipation
M Furnari, E Savarino, L Bruzzone, A Moscatelli, L Gemignani, ...
J Gastrointestin Liver Dis 21 (2), 157-163, 2012
872012
Achalasia with dense eosinophilic infiltrate responds to steroid therapy
E Savarino, L Gemignani, P Zentilin, N De Bortoli, A Malesci, L Mastracci, ...
Clinical gastroenterology and hepatology 9 (12), 1104-1106, 2011
722011
Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia
E Savarino, M Corbo, P Dulbecco, L Gemignani, E Giambruno, ...
World Journal of Gastroenterology: WJG 19 (17), 2668, 2013
582013
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients
L Gemignani, V Savarino, M Ghio, A Parodi, P Zentilin, N de Bortoli, ...
Seminars in Arthritis and Rheumatism 42 (5), 522-529, 2013
372013
The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors
M Furnari, A Buda, G Delconte, D Citterio, T Voiosu, G Ballardini, ...
J Gastrointestin Liver Dis 26 (2), 151-156, 2017
182017
Measurement of oro-caecal transit time by magnetic resonance imaging
E Savarino, V Savarino, M Fox, G Di Leo, M Furnari, E Marabotto, ...
European Radiology 25, 1579-1587, 2015
182015
Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis
E Savarino, M Ghio, E Marabotto, P Zentilin, G Sammito, G Cittadini, ...
Recenti Progressi in Medicina 100 (11), 512-516, 2009
162009
Sa2045 Relationship between drug serum concentration and clinical activity in patients with Crohn disease who achieved remission with adalimumab-a prospective study
G Bodini, V Savarino, V Fazio, L Assandri, P Dulbecco, L Gemignani, ...
Gastroenterology 5 (142), S-388, 2012
82012
Tu1169 Correlation Between Adalimumab Trough Serum Concentration, Anti-Adalimumab Antibodies and TNF-α Levels With Clinical Outcome in Patients Affected by Crohn's Disease
G Bodini, V Savarino, P Dulbecco, L Assandri, L Bruzzone, F Mazza, ...
Gastroenterology 5 (144), S-780, 2013
52013
Sa2058 Efficacy of Partially Hydrolyzed Guar Gum in Reducing Methane Excretion and Clinical Manifestation of Subjects Suffering From Irritable Bowel Syndrome
M Furnari, L Bruzzone, E Savarino, L Gemignani, A Moscatelli, G Bodini, ...
Gastroenterology 5 (142), S-391, 2012
42012
Su1061 How Many Suspected Laryngopharyngeal Reflux are Confirmed as GERD? a MII-pH Study
I Martinucci, N de Bortoli, E Savarino, A Nacci, V Ussia, B Fattori, M Bellini, ...
Gastroenterology 5 (142), S-413, 2012
32012
系统目前无法执行此操作,请稍后再试。
文章 1–20